Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-GBM Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00615186
What this trial is testing

Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy

Who this might be right for
Glioblastoma Multiforme
Bradmer Pharmaceuticals Inc. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06607016
What this trial is testing

A Clinical Trial With KJ103 in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane Disease
Shanghai Bao Pharmaceuticals Co., Ltd. 12
Early research (Phase 1)Study completedNCT02658981
What this trial is testing

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Who this might be right for
GlioblastomaGliosarcomaRecurrent Brain Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Testing effectiveness (Phase 2)Study completedNCT01648348
What this trial is testing

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)Study completedNCT00003478
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 10
Testing effectiveness (Phase 2)Study completedNCT01213407
What this trial is testing

Dendritic Cell Cancer Vaccine for High-grade Glioma

Who this might be right for
Glioblastoma Multiforme
Activartis Biotech 87
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+6 more
Nanjing Bioheng Biotech Co., Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT06513338
What this trial is testing

Complement C5 mAb in the Treatment of Anti-GBM Disease

Who this might be right for
Autoimmune Diseases
Peking University First Hospital 16
Testing effectiveness (Phase 2)Study completedNCT02798406
What this trial is testing

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Who this might be right for
Brain CancerBrain NeoplasmGlioma+8 more
DNAtrix, Inc. 49
Early research (Phase 1)Active Not RecruitingNCT04197934
What this trial is testing

WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Who this might be right for
Anaplastic Astrocytoma, IDH-WildtypeGlioblastoma, IDH-WildtypeMetastatic Lung Non-Small Cell Carcinoma+2 more
Mayo Clinic 56
Testing effectiveness (Phase 2)Ended earlyNCT00923117
What this trial is testing

Sunitinib to Treat Recurrent Brain Cancer

Who this might be right for
Glioblastoma MultiformeMalignant GliomasAnaplastic Gliomas
National Cancer Institute (NCI) 87
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811297
What this trial is testing

Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers

Who this might be right for
Endometrial NeoplasmsOvarian NeoplasmsSoft Tissue Sarcoma (STS)+1 more
Advenchen Pharmaceuticals, LLC. 138
Not applicableStudy completedNCT03635385
What this trial is testing

Comparison of ANCA and Anti-GBM Auto-antibodies Removal Kinetics Between Plasma Exchanges and Immunoadsorption in Patients With ANCA-associated Vasculitis or Anti-GBM Disease

Who this might be right for
Kidney Failure, Acute
Assistance Publique Hopitaux De Marseille 40
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Not applicableStudy completedNCT02843230
What this trial is testing

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Who this might be right for
Glioblastoma
Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT01454596
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII

Who this might be right for
Malignant GliomaGlioblastomaBrain Cancer+1 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT03234712
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 62
Testing effectiveness (Phase 2)Ended earlyNCT01778530
What this trial is testing

TRC105 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
National Cancer Institute (NCI) 2
Next Page